1	Un	Un		C0205447_1	calificador_1	0-2	98_QUEST_clinical_caseMIR	SENT1	-	-
2	paciente	paciente	NCCS000	C0030705	persona	3-11	98_QUEST_clinical_caseMIR	SENT1	-	-
3	diagnosticado	diagnosticar	VMP00SM	-	-	12-25	98_QUEST_clinical_caseMIR	SENT1	-	-
4	de	de	SPS00	C0332285	atributo	26-28	98_QUEST_clinical_caseMIR	SENT1	-	-
5	asma	asma	NCMS000	C0004096#C0085129#C1319018#C1260881_1	trastorno_1	29-33	98_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
6	bronquial	bronquial	NC00SC0	C0004096#C0085129#C1319018#C1260881_2	trastorno_2	34-43	98_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
7	que	que	PR0CN000	-	-	44-47	98_QUEST_clinical_caseMIR	SENT1	-	-
8	está	estar	VAIP3S0	-	-	48-52	98_QUEST_clinical_caseMIR	SENT1	-	-
9	siendo	ser	VSG0000	-	-	53-59	98_QUEST_clinical_caseMIR	SENT1	-	-
10	tratado	tratar	VMP00SM	C0332293_1	atributo_1	60-67	98_QUEST_clinical_caseMIR	SENT1	-	-
11	con	con	SPS00	C0332293_2	atributo_2	68-71	98_QUEST_clinical_caseMIR	SENT1	-	-
12	esteroides	esteroide	NCMP000	C0301818#C0038317	sustancia	72-82	98_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
13	inhalados	inhalar	VMP00PM	-	-	83-92	98_QUEST_clinical_caseMIR	SENT1	-	-
14	a	a	SPS00	-	-	93-94	98_QUEST_clinical_caseMIR	SENT1	-	-
15	dosis	dosis	NCFN000	-	-	95-100	98_QUEST_clinical_caseMIR	SENT1	-	-
16	bajas	bajo	AQ0FP0	C0205251	calificador	101-106	98_QUEST_clinical_caseMIR	SENT1	-	-
17	(	(	Fpa	-	-	107-108	98_QUEST_clinical_caseMIR	SENT1	-	-
18	200	200		-	-	108-111	98_QUEST_clinical_caseMIR	SENT1	-	-
19	microgramos	microgramo	NCMP000	C0439211	calificador	112-123	98_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	124-126	98_QUEST_clinical_caseMIR	SENT1	-	-
21	budesonida	budesonida	NC00SC0	C0054201	producto#sustancia	127-137	98_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
22	cada	cada	NC00SC0	C0456695_1	calificador_1	138-142	98_QUEST_clinical_caseMIR	SENT1	-	-
23	12	12	Z	C0456695_2	calificador_2	143-145	98_QUEST_clinical_caseMIR	SENT1	-	-
24	horas	hora	NCFP000	C0456695_3	calificador_3	146-151	98_QUEST_clinical_caseMIR	SENT1	-	-
25	)	)	Fpt	-	-	151-152	98_QUEST_clinical_caseMIR	SENT1	-	-
26	y	y	CC	C1706368	calificador	153-154	98_QUEST_clinical_caseMIR	SENT1	-	-
27	medicación	medicación	NCFS000	C0013227	sustancia	155-165	98_QUEST_clinical_caseMIR	SENT1	-	-
28	de	de	SPS00	C0332285	atributo	166-168	98_QUEST_clinical_caseMIR	SENT1	-	-
29	rescate	rescate	NCMS000	-	-	169-176	98_QUEST_clinical_caseMIR	SENT1	-	-
30	(	(	Fpa	-	-	177-178	98_QUEST_clinical_caseMIR	SENT1	-	-
31	salbutamol	salbutamol	NC00SC0	C0001927	producto	178-188	98_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
32	a	a	SPS00	-	-	189-190	98_QUEST_clinical_caseMIR	SENT1	-	-
33	demanda	demanda	NCFS000	C0441516	calificador	191-198	98_QUEST_clinical_caseMIR	SENT1	-	-
34	)	)	Fpt	-	-	198-199	98_QUEST_clinical_caseMIR	SENT1	-	-
35	acude	acudir	VMIP3S0	-	-	200-205	98_QUEST_clinical_caseMIR	SENT1	-	-
36	a	a	SPS00	-	-	206-207	98_QUEST_clinical_caseMIR	SENT1	-	-
37	control	control	NCMS000	C2587213	atributo	208-215	98_QUEST_clinical_caseMIR	SENT1	-	-
38	clínico	clínico	AQ0MS0	C0205210	calificador	216-223	98_QUEST_clinical_caseMIR	SENT1	-	-
39	periódico	periódico	NCMS000	C0332182	calificador	224-233	98_QUEST_clinical_caseMIR	SENT1	-	-
40	.	.	Fp	-	-	233-234	98_QUEST_clinical_caseMIR	SENT1	-	-

1	El	el	DA0MS0	-	-	235-237	98_QUEST_clinical_caseMIR	SENT2	-	-
2	paciente	paciente	NCCS000	C0030705	persona	238-246	98_QUEST_clinical_caseMIR	SENT2	-	-
3	refiere	referir	VMIP3S0	-	-	247-254	98_QUEST_clinical_caseMIR	SENT2	-	-
4	que	que	CS	-	-	255-258	98_QUEST_clinical_caseMIR	SENT2	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	259-261	98_QUEST_clinical_caseMIR	SENT2	-	-
6	los	el	DA0MP0	-	-	262-265	98_QUEST_clinical_caseMIR	SENT2	-	-
7	últimos	último	AO0MP0	-	-	266-273	98_QUEST_clinical_caseMIR	SENT2	-	-
8	3	3		-	-	274-275	98_QUEST_clinical_caseMIR	SENT2	-	-
9	meses	mes	NCMP000	C0439231	calificador	276-281	98_QUEST_clinical_caseMIR	SENT2	-	-
10	no	no	RN	C1298908	calificador	282-284	98_QUEST_clinical_caseMIR	SENT2	-	-
11	ha	haber	VAIP3S0	-	-	285-287	98_QUEST_clinical_caseMIR	SENT2	-	-
12	tenido	tener	VMP00SM	-	-	288-294	98_QUEST_clinical_caseMIR	SENT2	-	-
13	agudizaciones	agudización	NCFP000	-	-	295-308	98_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Negacion
14	y	y	CC	C1706368	calificador	309-310	98_QUEST_clinical_caseMIR	SENT2	-	-
15	que	que	PR0CN000	-	-	311-314	98_QUEST_clinical_caseMIR	SENT2	-	-
16	utiliza	utilizar	VMIP3S0	-	-	315-322	98_QUEST_clinical_caseMIR	SENT2	-	-
17	el	el	DA0MS0	-	-	323-325	98_QUEST_clinical_caseMIR	SENT2	-	-
18	salbutamol	salbutamol	NC00SC0	C0001927	producto	326-336	98_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
19	una	una		C0205447_1	calificador_1	337-340	98_QUEST_clinical_caseMIR	SENT2	-	-
20	vez	vez	NCFS000	-	-	341-344	98_QUEST_clinical_caseMIR	SENT2	-	-
21	al	al	SP+DA	-	-	345-347	98_QUEST_clinical_caseMIR	SENT2	-	-
22	día	día	NCMS000	C0439228#C0332169	calificador	348-351	98_QUEST_clinical_caseMIR	SENT2	-	-
23	.	.	Fp	-	-	351-352	98_QUEST_clinical_caseMIR	SENT2	-	-

1	Únicamente	únicamente	RG	-	-	353-363	98_QUEST_clinical_caseMIR	SENT3	-	-
2	tiene	tener	VMIP3S0	-	-	364-369	98_QUEST_clinical_caseMIR	SENT3	-	-
3	disnea	disnea	NCFS000	C0013404#C0553668	hallazgo	370-376	98_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
4	al	al	SP+DA	-	-	377-379	98_QUEST_clinical_caseMIR	SENT3	-	-
5	subir	subir	VMN0000	-	-	380-385	98_QUEST_clinical_caseMIR	SENT3	-	-
6	cuestas	cuesta	NCFP000	-	-	386-393	98_QUEST_clinical_caseMIR	SENT3	-	-
7	y	y	CC	C1706368	calificador	394-395	98_QUEST_clinical_caseMIR	SENT3	-	-
8	algunas	alguno	DI0FP0	C0205392	calificador	396-403	98_QUEST_clinical_caseMIR	SENT3	-	-
9	noches	noche	NCFP000	C0240526	calificador	404-410	98_QUEST_clinical_caseMIR	SENT3	-	-
10	duerme	dormir	VMIP3S0	-	-	411-417	98_QUEST_clinical_caseMIR	SENT3	-	-
11	de	de	SPS00	C0332285	atributo	418-420	98_QUEST_clinical_caseMIR	SENT3	-	-
12	forma	forma	NCFS000	C0348078	atributo	421-426	98_QUEST_clinical_caseMIR	SENT3	-	-
13	irregular	irregular	AQ0CS0	C0205271	calificador	427-436	98_QUEST_clinical_caseMIR	SENT3	-	-
14	por	por	SPS00	C0678226	atributo	437-440	98_QUEST_clinical_caseMIR	SENT3	-	-
15	la	el	DA0FS0	-	-	441-443	98_QUEST_clinical_caseMIR	SENT3	-	-
16	tos	tos	NCFS000	C0010200_1	entidad_observable#hallazgo_1	444-447	98_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
17	.	.	Fp	-	-	447-448	98_QUEST_clinical_caseMIR	SENT3	-	-

